Neurophet
Latest round
- Series C
Last raised
- Nov 2023
Total raised
- $40M
Investors
- 20
About Neurophet
Based in South Korea, Neurophet Inc.Neurophet Inc. specializes in AI-powered brain imaging analysis, aimed at aiding medical professionals in diagnosing and managing brain diseases. The firm's founders are Donghyeon Kim and Junkil Been, who also serves as the CEO.Neurophet specializes in AI-driven brain imaging analysis solutions designed to support the entire lifecycle of brain diseases. Their core offerings include products such as Neurophet AQUA, which focuses on the analysis of conditions like Multiple Sclerosis and Alzheimer's disease, alongside advanced neuromodulation techniques including transcranial Direct Current Stimulation (tDCS). These products are aimed at medical professionals, including neurologists and radiologists, and are utilized in various clinical settings to enhance treatment planning, drug efficacy monitoring, and clinical research imaging analysis. The company serves a global client base, including partnerships with notable institutions like the Department of Radiology at the University of Washington and Nanyang Technological University in Singapore.Neurophet generates revenue primarily through partnerships and subscription-based models, enabling direct access to their innovative imaging analysis services. Clients, including hospitals and research institutions, engage with Neurophet for ongoing support and access to its suite of products, facilitating long-term relationships and repeat business. For instance, Neurophet AQUA is positioned as a flagship product for Multiple Sclerosis analysis, involving licensing agreements or service contracts that provide continuous updates and support.In February 2024, Neurophet Inc. Neurophet aims to develop and launch new products that enhance their existing solutions, with specific timelines for market entry to be established post-collaboration. Expansion plans include targeting additional markets in Europe and North America by 2025, furthering their reach in the neuroimaging sector.
Who invested in Neurophet
20 investors across 6 rounds
See all investors in Neurophet
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neurophet
Who invested in Neurophet?
Neurophet has 20 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurophet raised?
Neurophet has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Neurophet last raise money?
Neurophet's most recent round on record is a Series C, in Nov 2023.
What does Neurophet do?
Based in South Korea, Neurophet Inc.
Where is Neurophet headquartered?
Neurophet is headquartered in Seoul, South Korea.
Which VCs invest in companies like Neurophet?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at Neurophet's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Neurophet? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.